glofitamab,lenalidomide,obinutuzumab,tocilizumab
roche
['mantle,(-dismantle)', 'obinu', ' ipi ', 'glofitamab', ' lena', 'lymphoma', 'lymsm']
next up: 12 fixed cycles glofitamab in r/r mantle cell lymphoma. 37 pts, most with refractory dx &amp; previous btk tx. high cr rates &gt;70%, with 72% of cr pts with ongoing remissions. more tox but higher cr with higher dose of pretx obinu. most common ae was gr1-2 crs. #ash22 #lymsm 
#lymsm & #mmsm hematologist & patient-reported outcomes researcher @CUHematology. Founder of https://t.co/kN6qeGXfg5, @inTrainingDoc & @inHouseMag. ??????